RecruitingNCT07301242

Population Pharmacokinetics and Pharmacodynamics of Ciprofol

Population Pharmacokinetic/Pharmacodynamic Modeling of Ciprofol in Elderly Patients Undergoing Orthopedic Limb Surgery


Sponsor

Shanghai Geriatric Medical Center

Enrollment

50 participants

Start Date

Oct 28, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to learn how the anesthetic drug ciprofol works in older adults who are having limb surgery under general anesthesia at Shanghai Geriatric Medical Center. The study will help researchers build a population model to better understand how the drug moves through the body (PK) and how it affects patients (PD). This model may help doctors use a Target-Controlled Infusion (TCI) system to adjust the drug dose more precisely. The main question it aims to answer is: Does ciprofol work safely and effectively in older adults during orthopedic surgery? Participants already receiving ciprofol as part of their regular anesthesia care will: 1. Provide blood samples at different time points during and after surgery. 2. Have their vital signs and anesthesia-related data recorded before, during, and after surgery. 3. Be monitored for side effects and recovery indicators such as the Aldrete score and signs of postoperative delirium. Researchers will use this information to: 1. Build and test a population PK/PD model for ciprofol. 2. Simulate recommended TCI dosing plans. 3. Explore how individual responses to ciprofol relate to recovery and safety outcomes. This study may help improve anesthesia care for elder adults by making drug dosing safer and more effective.


Eligibility

Min Age: 65 Years

Inclusion Criteria6

  • Age ≥65 years;
  • BMI: 18-30 kg/m²;
  • ASA physical status classification I-III;
  • Scheduled for elective orthopedic limb surgery under general anesthesia;
  • Expected duration of surgery \>30 minutes;
  • Willing to participate and able to provide written informed consent.

Exclusion Criteria10

  • Known allergy to ciprofol or related medications, or any contraindication to their use;
  • Preoperative cognitive impairment;
  • History of severe cerebrovascular disease or related complications;
  • History of neuromuscular system diseases or psychiatric disorders;
  • History of sedative medication use;
  • History of alcohol abuse or substance use disorder;
  • Bradycardia (heart rate \<60 beats per minute);
  • Hypotension (mean arterial pressure \<55 mmHg);
  • QT interval prolongation;
  • Uncooperative or unable to communicate effectively.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCiprofol

Ciprofol is used as an intravenous anesthetic agent for sedation and anesthesia induction/maintenance in elderly patients undergoing elective orthopedic limb surgery. In this observational study, ciprofol is administered according to standard clinical practices, and data on its pharmacokinetics, pharmacodynamics, safety, and effectiveness in this specific population will be collected.


Locations(1)

Shanghai Geriatric Medical Center

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07301242


Related Trials